Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national blog main
15
×
biotech
boston blog main
boston top stories
clinical trials
national top stories
san francisco blog main
new york blog main
san francisco top stories
startups
boston
deals
fda
new york top stories
cancer
cancer drugs
investing
venture capital
biotech ipos
ipo
medical device
national
san diego blog main
san diego top stories
texas blog main
texas top stories
third rock ventures
abbvie
alexion pharmaceuticals
alzheimer's disease
biogen
blackstone group
cancer immunotherapy
david goldstein
depression
eli lilly
epilepsy
essential tremor
europe blog main
What
research
15
×
medicines
new
biotech
drug
ipo
cancer
companies
drugs
san
aims
antonio
based
ceo
disease
gene
genetic
ipos
medicine
praxis
precision
proteins
raised
revolution
science
startup
stop
targets
therapeutics
way
week
abbvie
accelerator
adds
advance
alex
alike
alliance
alzheimer’s
announced
Language
unset
Current search:
" national blog main "
×
research
×
@xconomy.com
3 years ago
Praxis Precision Medicines Leads Way as Three More Biotechs Prep IPOs
@xconomy.com
4 years ago
AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact
@xconomy.com
4 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
Revolution Medicines Maps Out an IPO to Reach Cancer’s Frontiers
@xconomy.com
4 years ago
Pfizer Taps Insilico Medicine to Use AI for Drug Target Discovery
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@xconomy.com
5 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
5 years ago
San Antonio to Honor Regenerative Medicine Pioneer Stephen Badylak
@xconomy.com
5 years ago
UT Health San Antonio Plans New Accelerator for Faculty Research
@xconomy.com
5 years ago
Biolinq Adds $4.75M to Advance Glucose Monitoring Biosensor Patch
@xconomy.com
5 years ago
Nominations Open for San Diego’s Inaugural Xconomy Awards
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More